Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
75 participants
INTERVENTIONAL
2014-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
550 mg naproxen sodium and 30mg codeine
Preoperatively patients received oral naproxen sodium codeine, postop contramal infused by PCA, and postoperative contramal consumption, side effects pain intensity measured by VAS.
550 mg naproxen sodium and 30mg codeine
Postoperative contramal consumption, pain intensity, side effects
300 mg paracetamol and 30 mg codeine
Preoperatively patients received oral paracetamol codeine, postop contramal infused by PCA, and postoperative contramal consumption, side effects pain intensity measured by VAS.
300 mg paracetamol and 30 mg codeine
Postoperative contramal consumption, pain intensity, side effects
Placebo
Preoperatively patients received oral placebo tablet, postop contramal infused by PCA, and postoperative contramal consumption, side effects pain intensity measured by VAS.
placebo tablet
Postoperative contramal consumption, pain intensity, side effects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
550 mg naproxen sodium and 30mg codeine
Postoperative contramal consumption, pain intensity, side effects
300 mg paracetamol and 30 mg codeine
Postoperative contramal consumption, pain intensity, side effects
placebo tablet
Postoperative contramal consumption, pain intensity, side effects
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* peptic ulcer disease
* hepatic and renal dysfunction,
* emergency surgery
* inability to provide informed consent
16 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Yildirim Beyazit Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reyhan Polat
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reyhan Polat, MD
Role: PRINCIPAL_INVESTIGATOR
Ministry of Health
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pstoperative pain
Identifier Type: -
Identifier Source: org_study_id